I have a background in biology and mathematics, with a bachelor degree in mathematical biology (ecology) and a master degree in statistics, both from NTNU in Trondheim. In 2016, I defended my PhD at department of Neurology (University of Oslo) on genetics and epigenetics of multiple sclerosis. Since 2015 I have worked with epigenetic epidemiology in MoBa at the Norwegian Institute of Public Health, first at the department of chronic diseases, and since 2018 at the Centre for Fertility and Health, where I take an interest in reproductive biology and epidemiology of pregnancy health.
Between 2016 and 2020 I was a post.doc at Oslo Centre for Biostatistics and Epidemiology, working on epigenetic markers for early detection of cancers, focusing on melanoma and how UV exposure could influence DNA methylation, where DNA methylation would act as a mediator of risk between UV exposure and skin cancer. For this we used blood samples from a large prospective Norwegian cancer cohort; the Norwegian Woman and Cancer (NoWaC) study. In 2019 I was a visiting scientist in the Laboratory for Precision Environmental Epidemiology, at Columbia University in New York for almost a year, working with Andrea Baccarelli and his group on epigenetic epidemiology.
I have recently also been involved in working with advanced computational epidemiology in large Norwegian registry linkages, where we are interested in modeling how geographical and familial risk interacts for different diseases. This is done using observations and family linkage on everyone ever lived in Norway for the last 80 years.
In the last year, I have been the lead analysis for a large epigenetic project in MoBa, where we are interested in how artificial reproductive technology (e.g. IVF) affect the epigenetic profile of the offspring.
I look forward to work with PharmaTox initiative, and to continue my work on pregnancy health, and to bridge methodological and epidemiological research in pregnancy safety and reproductive biology.